Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-023651 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
2,000
Total Value
$140,431.26
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 300 | $68.27 | $20,481.00 | 183,071 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 300 | $69.43 | $20,829.00 | 182,771 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 994 | $70.45 | $70,027.30 | 181,777 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 406 | $71.66 | $29,093.96 | 181,371 | Direct | โ | View Details |